To further explore the effect of GFAT1-O-GlcNAcylation signal axis on liver cancer cells in vivo, we utilized the CRISPR-Cas9 system to silence endogenous GFAT1 in MHCC-97H cells. This evidence concerns the gene GFPT1 and liver cancer.